China’s next big growth story comes with a new twist – its rapidly graying population. Today one in every four people in the world over 64 is from China. In twenty years this is forecast to reach one in three. PE investment has poured into the health sector as demand for everything from hospital beds to new hips and drugs is expected to rocket. But … Continue reading Standing out in China’s medical services boom
It might seem an oxymoron that the world’s most admired company can have an image problem. But the backlash that hit Apple in 2010 after a spate of worker suicides at its outsourced assembly plant in Shenzhen, underscored that reputation is now much more than just great products and profits. Ethical behaviour increasingly matters, especially when millions of consumers on social media are ready to … Continue reading Making ESG Count in Reputation Management
Reports of a fresh wave of Chinese listings are likely to cheer IPO sponsors but elicit a loud groan from investors. Will this time around be different? The wounds from the recent boom-to-bust history of Chinese listings amid accounting scandals, missed numbers and falling share prices are still raw. This means Chinese companies will return to very different public markets and they will have to … Continue reading Return of Chinese Listings? Overcoming Reputational Fallout
A collective shiver went through Hong Kong last week after it was revealed a deadly new strain of bird flu had broken out in China. Coming on the tenth anniversary of SARS, this inevitably brought back memories of an unhappy chapter when Hong Kong went into lockdown and paralysis. For one of the most congested cities on earth it was a fraught period as companies … Continue reading Bird flu returns to China: Crisis communications – are you ready?